Highly passionate and innovative biopharmaceutical executive with multinational commercial expertise leading global, regional, and local cross-functional teams, assets, and brands across the full drug development pathway. Peter’s strategic and marketing experience spans large, mid-size, and start-up pharmaceutical and biotechnology companies (Novartis, Gilead, Lundbeck, Vertex Pharmaceuticals, Breath Therapeutics/Zambon) which includes leadership roles for several global product launches. A results-oriented leader who has effectively managed and delivered large launch portfolios, Peter understands dynamic global and regional market conditions and knows how to successfully position and commercialize complex products that generate sales and increase value.
Known for fostering inclusive and empowering cultures that inspire and bring out the best in teams, he consistently acts as a catalyst and accelerator to streamline business processes and cultivate new ideas while inspiring teams to think bigger and push further. Peter is also an effective communicator and leader, creating collaborative and vibrant working environments within global cultures. He has dual U.S. and French citizenship, speaks five languages, and draws on more than 30 years of multinational experience leading global sales and marketing efforts in the pharmaceutical and biotechnology industries.
For the past 15 years, Peter has specialized in launching specialty and rare disease products in gastrointestinal, infectious disease, neuroscience, and respiratory diseases. In preparing these launches, he has built cohesive commercial organizations and led these teams in designing launch strategies and roadmaps that deliver results, creating and operationalizing strong Access and Health Economic evidence, developing patient support programs, forecast tools and analytics, government policy, professional and patient advocacy collaborations, and disease awareness and launch campaigns.